RxDoctor Payments Data

Diane Smith, APRN

Dermatology · Reno, NVNPI 1316139413

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.3% of the total across 509 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations.

$15,849in general payments, 2019–2025

Across 509 payments — averaging $31.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Johnson & Johnson$2K
  • Incyte Corporation$2K
  • Lilly USA, LLC$1K
  • Sun Pharmaceutical Industries Inc.$1K
  • UCB, Inc.$861
  • plus $6K from 23 others

What the payments were for

  • Consulting fees$4003%
  • Food & beverage$14,79093%
  • Education$6584%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,849 in reported general payments places this provider in the 85th percentile of 78 dermatology providers in Nevada.

See all dermatology providers in Nevada

Medicare billing

Part B allowed, 2024
$117,924
Medicare patients
393
Services billed
2,147

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate88$3,725
ValacyclovirValacyclovir Hcl66$2,583
Ketoconazole83$1,650
Fluorouracil26$1,585
Triamcinolone Acetonide80$1,102
Metronidazole16$922
Minoxidil47$705
Alclometasone Dipropionate34$660
Desonide13$618
Doxycycline Hyclate23$380
Hydroxyzine Hcl13$185
Acyclovir14$177
Cephalexin14$58

Paid to pharmacies, not to this prescriber.

Other dermatology in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →